Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2328
+0.0026 (1.13%)
At close: Jul 28, 2026, 4:00 PM EDT
0.2300
-0.0028 (-1.20%)
Pre-market: Jul 29, 2026, 4:02 AM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $9.55 million as of July 28, 2026. Its market cap has decreased by -89.36% in one year.
Market Cap
9.55M
Enterprise Value
-34.81M
1-Year Change
-89.36%
Ranking
Category
Stock Price
$0.23
ChartMarket Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $9.55M, an increase of 2.71%. That is a compound annual growth rate of 0.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 9.55M | -63.40% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 10.71M |
| Lisata Therapeutics | 10.56M |
| Chemomab Therapeutics | 10.30M |
| Lunai Bioworks | 10.16M |
| BioVie | 10.03M |
| Theriva Biologics | 9.80M |
| Curis | 9.41M |
| Aspire Biopharma Holdings | 9.38M |